Baird’s European Healthcare Team off to a Stellar Start in 2022
Coming off a record 2021 when the Heathcare team closed over 45 transactions, Baird’s Global Healthcare Investment Banking team is continuing its transaction momentum with a strong start to 2022. The team now includes over 40 investment bankers and continues to rapidly expand, especially in Europe.
Led by London based Managing Director, Andrew Nicholson, Baird has built a dedicated European Healthcare Investment Banking team of around 10 bankers. The team has also expanded its global focus on pharma services through the recent addition of Tom Cowap in London who focuses on pharma services and pharma tech. Baird’s growing team significantly strengthens its European healthcare coverage and cross-border capabilities.
It’s an exciting time for Baird’s European Healthcare team. Expanding this team has been and continues to be a key focus for Baird. The investment in people and our strong momentum in closing transactions is incredibly exciting and we are ever more strongly positioned to serve companies and investors in European healthcare.
- Andrew Nicholson, Managing Director, Head of Healthcare Europe
Baird’s European Healthcare team has already closed four deals in the first few months of 2022 and expects to announce more deals in the coming months:
Healthcare Equipment
Healthcare Provider
Pharma Services
Pharma ServicesConnect with our team to learn more about these transactions. We welcome the opportunity to share more about Baird’s European Healthcare coverage and what to expect in 2022.
Contact Senior Members of Baird’s European Healthcare Team
Andrew Nicholson
+44 7740 958 426
anicholson@rwbaird.com
Tom Cowap
+44 7552 342 477
tcowap@rwbaird.com
Alexandre Jourdan
+44 7860 272 598
ajourdan@rwbaird.com
